Citius Pharmaceuticals raises $6.0M in registered direct offering for LYMPHIR launch

Citius Pharmaceuticals, Inc.

Gross proceeds ~$6.0M; net ~$5.5M after placement agent fees and expenses.
Offering: 3,973,510 shares/pre-funded warrants plus 3,973,510 common warrants at $1.51/share.
Common warrants exercisable at $1.40/share, 5-year term; pre-funded warrants at $0.0001/share.
Net proceeds to support commercial launch of LYMPHIR™ and other product candidates.
H.C. Wainwright acted as placement agent; 7.0% cash fee and 278,146 placement agent warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.